Loading...

Home
ETF
ABUS

ABUS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ABUS News

Arbutus Biopharma Reports Q4 Earnings with Strong Revenue Growth

Mar 23 2026seekingalpha

Arbutus and Take-Two Options Trading Activity

Mar 04 2026NASDAQ.COM

Moderna-Arbutus-Genevant Patent Agreement: Wall Street Views It as Suboptimal, Yet Alleviates Pressure on MRNA Shares

Mar 04 2026stocktwits

Midday Market Moves: Notable Stock Fluctuations

Mar 04 2026CNBC

Moderna Settles Patent Dispute with Arbutus and Genevant

Mar 04 2026seekingalpha

STAAR Surgical Reports Disappointing Q4 Results, Shares Plummet

Mar 04 2026Benzinga

Moderna Settles for $950 Million with Arbutus, Eyes Future Growth

Mar 04 2026Benzinga

Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and Others

Mar 04 2026Barron's

Moderna Reaches Settlement in Lawsuit: Implications for Its Stock.

Mar 04 2026Barron's

Moderna Shares Surge as Major Risk is Removed.

Mar 04 2026Barron's

Box Inc Q4 Earnings Exceed Expectations

Mar 04 2026Benzinga

Moderna Settles for Up to $2.25 Billion with Arbutus and Genevant

Mar 03 2026stocktwits

Moderna Settles $2.25 Billion Patent Dispute with Genevant and Arbutus

Mar 03 2026Newsfilter

Delaware Judge Dismisses Key Defenses in Moderna Patent Case

Feb 18 2026seekingalpha

Arbutus Biopharma Shares Rise 10% After Patent Ruling

Feb 02 2026seekingalpha

Health Care Stocks Decline as NYSE Health Care Index Eases 0.5%

Jan 16 2026Yahoo Finance